THE World Health Organization (WHO) says accelerated research and development (R&D) in new tools for malaria prevention and treatment is key if the world is to eradicate malaria in the foreseeable future.
By HealthTimes Reporter
This recommendation came in a report from WHO’s Strategic Advisory Group on Malaria Eradication (SAGme).
Currently, less than 1% of funding for health R&D investment goes to developing tools to tackle malaria.
“To achieve a malaria-free world we must reinvigorate the drive to find the transformative strategies and tools that can be tailored to the local situation. Business as usual is not only slowing progress, but it is sending us backwards,” according to Dr Marcel Tanner, Chair of the SAGme.
WHO also flags the urgent need for progress to advance universal health coverage and improve access to services, and better surveillance to guide a more targeted malaria response.
The group has published the executive summary of its report ahead of a WHO-hosted forum on “Rising to the Challenge of Malaria Eradication” to be held in Geneva on 9 September 2019.
The SAGme team took three years to come up with this report.